Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



VANLENT ANNE Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 4 VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.27, valued at $68.1k
01/03/2023 3 VANLENT ANNE (Director) has filed a Form 3 on ObsEva SA
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/01/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $2.25, valued at $45k
12/18/2020 4 VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Granted 12,000 options to buy @ $4.72, valued at $56.6k
06/15/2020 4 VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 14,210 options to buy @ $4.1, valued at $58.3k
12/06/2019 4 VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Granted 10,000 options to buy @ $3.02, valued at $30.2k
06/14/2019 4 VANLENT ANNE (Director) has filed a Form 4 on Vaxart, Inc.
Txns: Granted 9,000 options to buy @ $0.68, valued at $6.1k
Granted 12,700 options to buy @ $0.68, valued at $8.6k
05/13/2019 4 VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Converted 20,983 shares @ $0
Bought 5,000 shares @ $10, valued at $50k
Converted 107,977 preferred shares @ $0
Converted 47,807 preferred shares @ $0
05/08/2019 4 VANLENT ANNE (Director) has filed a Form 4 on Trevi Therapeutics, Inc.
Txns: Granted 23,684 options to buy @ $10, valued at $236.8k
05/07/2019 3 VANLENT ANNE (Director) has filed a Form 3 on Trevi Therapeutics, Inc.
11/19/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/30/2018 4/A VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Granted 10,000 options to buy @ $4.25, valued at $42.5k
07/27/2018 4 VANLENT ANNE (Director) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP
Txns: Granted 8,000 options to buy @ $4.25, valued at $34k
12/11/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2017 4 VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Granted 12,500 shares @ $0
05/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
12/27/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
12/01/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
12/01/2016 3 Form 3 - Initial statement of beneficial ownership of securities
11/30/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
08/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
08/18/2016 3 Form 3 - Initial statement of beneficial ownership of securities
06/15/2016 4 VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Granted 12,500 options to buy @ $2.26, valued at $28.3k
05/13/2016 4 VANLENT ANNE (Director) has filed a Form 4 on Aviragen Therapeutics, Inc.
Txns: Granted 20,000 options to buy @ $1.5, valued at $30k
08/13/2015 4 VANLENT ANNE (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc.
Txns: Granted 5,000 options to buy @ $2.49, valued at $12.5k
06/29/2015 4 VANLENT ANNE (Director) has filed a Form 4 on Aegerion Pharmaceuticals, Inc.
Txns: Granted 18,000 options to buy @ $17.98, valued at $323.6k
06/24/2015 4 VANLENT ANNE (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc.
Txns: Bought 35,000 shares @ $2.1969, valued at $76.9k
06/22/2015 4 VANLENT ANNE (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $3.76, valued at $37.6k
06/17/2015 4 VANLENT ANNE (Director) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 10,000 options to buy @ $2.69, valued at $26.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy